Advertisement

Meyka AI - Contribute to AI-powered stock and crypto research platform
Meyka Stock Market API - Real-time financial data and AI insights for developers
Advertise on Meyka - Reach investors and traders across 10 global markets
Loading...

Immutep Limited

PRRUFPNK
Healthcare
Biotechnology
$0.25
$0.00(0.00%)
U.S. Market opens in NaNh NaNm

Immutep Limited (PRRUF) Stock Overview

Explore Immutep Limited’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap368M
P/E Ratio-12.21
EPS (TTM)$-0.03
ROE-0.27%
Fundamental Analysis

AI Price Forecasts

1 Month$0.25
3 Months$0.29
1 Year Target$0.25

PRRUF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Immutep Limited (PRRUF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 47.45, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.25.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -12.21 and a market capitalization of 368M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
38.89%
6-Month Change
31.58%
Year-to-Date (YTD) Change
-21.88%
1-Year Change
25.00%
3-Year Change
25.00%
5-Year Change
-13.79%
All-Time (Max) Change
8233.33%

Contact Information

61 2 8315 7003
Australia Square, Sydney, NSW, 2000

Company Facts

IPO DateFeb 22, 2012
CountryAU
Actively Trading

Frequently Asked Questions